Member Info for LurkingNoob

What more could we actually expect from results than this? The way forward has been identified and its a strong, well run business. Plenty of pent up travel demand and lots of contracts. Those investing rather than trading have no concerns about the future.

Definitely is when the two drugs involved are pictured in the article below and are clearly labelled "intravenous use only"

https://www.fiercepharma.com/pharma/lilly-covid-19-antibody-combo-cuts-hospitalizations-and-deaths-by-87

Spiked up, came down sharply. I've long since given up looking at after hours as a clue to the days trading in the USA. Many times seen astronomical rises in pre-market seconds before the buzzer disappear the minute the market opens so retail traders jump in to an immediate loss situation.

Why extra cash? Share buyback. Presumably no takeover targets so aiming to push their sp up.

Also buying Standard Life pensions? If so, should we expect even more operating profit next year?

Fwd sales (orders placed) need to be taken into account in the valuation - they've definitely had plenty of time to build those up! - as well as market cap of the product they are hoping to take market share from.

Just me hoping that they are manufacturing the drugs via a large British firm like GSK who not only have well established supply lines but are also aiming to split their business in two in 2022 with one focusing on Biopharma and the other on consumer health care? They could make a big splash with a buyout at that point

How the hell has this gone down this morning?!

Bluebelly, as posts can often be read into incorrectly this is a question I simply have no clue as to the answer on not an attack on anyone or anything.

How long does it take to manufacture a sufficient amount of a new drug - in this case StemprintER - to make the launch of a new company selling just that one drug viable? Bit pointless opening a store with empty shelves...

Also, any idea who is manufacturing it? I can't see Accustem being the large-scale producer so presumably its being outsourced.

LeddachJach may suggest a certain something by Friday. I'm going to predict that number by tomorrow :)

Saw something on this yesterday on Twitter. It's not just a case of the physical shortage but that futures are shorted on silver to keep the price down while hedge funds make moneyoff of it. If those shorts expire they have to buy the stocks at higher prices which then pushes the price up further.

Oh what a shame for investors in Silver be that physical, miners like HOCH & POLY or ETF trackers (which were all up circa 9% first thing this morning)!

BTW, AMC Entertainment has a shedload of shorts expiring Monday through Thursday at prices far, far, far lower than Fridays $13+ close.

It was. The updated timeline shown on the PDF for investors clearly has the * in the first period of the first quarter of 2021 for new from Brazil on COVID-19 trials. That is January and its now February. The ink was barely dry before the first deadline was missed :0

Is it a big deal? Not really, but lsh have long since been complaining about the BOD's lassez faire attitude to deadlines and now we've quit AIM at the next level this may not be skirted over.

Probably but whilst lsh have read all about the products the saying that 'a picture says a thousand words' has never been more apt. It's a slick presentation that will attract new investors who wouldn't know their efficacy from efficiency and want the start, interim and final data dates narrowed down by month so it's clear what's happening, where, who by and when. That's now been done (let's just hope they stick to the dates!)

Well done TILS

LeddachJack let's hope so. Wouldn't want your Friday sp guess to be wrong, would we? ;)

A few US firms have gone the direct listing route recently rather than IPO. The three main differences are:
1. It doesn't require banks to back the listing by underwriting the stock.
2. The sale is of existing shares rather than of new ones
3. it doesn't raise capital by diluting the shares

Has anyone got any idea how many shares are outstanding? Am presuming that the low opening cash position of Accustem (£1m?) makes this impossible unless the outstanding float is large but it would protect shareholder value and still be sold to II's

Agreed Fools. Can't buy into fwd/recurring sales based on 'soft launch' only in Italy. Accustem one to accumulate and watch grow, not sell for pennies in the £ straight after the initial fund raising and launch.

No. "The value of your investment can go down as well as up"

Having held stocks here since mid-July like many I've been +100%/-60% and everything in between! A continuation of the retrace until 26th would be most welcome as I've no more funds available until I get paid and would welcome some more that lower rather than increase my 149p avg ??

Hopefully will push up towards 500p in the coming weeks. Always some 'sell on news' effect post updates before people snaffle up the bargain before it pushes back up

Alignment of FTSE/NASDAQ being what the sage's of the trading world were pointing towards. (Sorry, can't remember who). The clever ones are doubtless still counting their extra cash.

I'm still fairly new to this so ain't one of them. Not complaining about being 30p in the green though :)

Bits not to like? Customer retention below the level of H1 and results at the upper end of the range of targets but not above them.

LeddachJack, what's your prediction by Friday? ;)